<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .a, a { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 2; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, lower-latin)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 #l5 {padding-left: 0pt;counter-reset: d2 1; }
 #l5> li>*:first-child:before {counter-increment: d2; content: counter(d2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: e1 1; }
 #l6> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt; }
 #l7> li>*:first-child:before {content: "□ "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 li {display: block; }
 #l8 {padding-left: 0pt;counter-reset: g1 2; }
 #l8> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: h1 1; }
 #l9> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 li {display: block; }
 #l10 {padding-left: 0pt;counter-reset: i1 1; }
 #l10> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 li {display: block; }
 #l11 {padding-left: 0pt;counter-reset: j1 1; }
 #l11> li>*:first-child:before {counter-increment: j1; content: counter(j1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: j1 0;  }
 li {display: block; }
 #l12 {padding-left: 0pt;counter-reset: k1 2; }
 #l12> li>*:first-child:before {counter-increment: k1; content: counter(k1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: k1 0;  }
 #l13 {padding-left: 0pt;counter-reset: k2 1; }
 #l13> li>*:first-child:before {counter-increment: k2; content: counter(k2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l13> li:first-child>*:first-child:before {counter-increment: k2 0;  }
 li {display: block; }
 #l14 {padding-left: 0pt;counter-reset: l1 2; }
 #l14> li>*:first-child:before {counter-increment: l1; content: counter(l1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l14> li:first-child>*:first-child:before {counter-increment: l1 0;  }
 li {display: block; }
 #l15 {padding-left: 0pt;counter-reset: m1 1; }
 #l15> li>*:first-child:before {counter-increment: m1; content: counter(m1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l15> li:first-child>*:first-child:before {counter-increment: m1 0;  }
 li {display: block; }
 #l16 {padding-left: 0pt;counter-reset: n1 1; }
 #l16> li>*:first-child:before {counter-increment: n1; content: counter(n1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l16> li:first-child>*:first-child:before {counter-increment: n1 0;  }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"></head><body><p class="s1" style="padding-top: 3pt;padding-left: 105pt;text-indent: 0pt;text-align: center;">PHARMACEUTICS (MPH)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 138pt;text-indent: -111pt;line-height: 115%;text-align: left;">MODERN PHARMACEUTICAL ANALYTICAL TECHNIQUES (MPH 101T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This subject deals with various advanced analytical instrumental techniques for identification, characterization and quantification of drugs. Instruments dealt are NMR, Mass spectrometer, IR, HPLC, GC etc.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">After completion of course student is able to know,</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Chemicals and Excipients</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">The analysis of various drugs in single and combination dosage forms</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Theoretical and practical skills of the instruments</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                              60 HOURS</p><ol id="l1"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 41pt;text-indent: -35pt;line-height: 86%;text-align: justify;">a. <span class="s3">UV-Visible spectroscopy</span>: Introduction, Theory, Laws, Instrumentation associated with UV-Visible spectroscopy, Choice of solvents and solvent effect and Applications of UV- Visible spectroscopy.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l2"><li data-list-text="b."><p class="s3" style="padding-left: 41pt;text-indent: -10pt;line-height: 87%;text-align: justify;">IR spectroscopy<span class="p">: Theory, Modes of Molecular vibrations, Sample handling, Instrumentation of Dispersive and Fourier - Transform IR Spectrometer, Factors affecting vibrational frequencies and Applications of IR spectroscopy</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c."><p class="s3" style="padding-left: 41pt;text-indent: -10pt;line-height: 88%;text-align: justify;">Spectroflourimetry: <span class="p">Theory of  Fluorescence,  Factors affecting fluorescence, Quenchers, Instrumentation and Applications of fluorescence spectrophotometer.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="d."><p class="s3" style="padding-left: 41pt;text-indent: -10pt;line-height: 89%;text-align: justify;">Flame  emission  spectroscopy  and  Atomic  absorption spectroscopy<span class="p">: Principle, Instrumentation, Interferences and Applications.</span></p></li></ol></li></ol><ol id="l3"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 9pt;text-align: justify;">NMR spectroscopy<span class="p">: Quantum numbers and their role in NMR,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Principle, Instrumentation, Solvent requirement in NMR, Relaxation process, NMR signals in various compounds, Chemical shift, Factors influencing chemical shift, Spin-Spin coupling, Coupling constant, Nuclear magnetic double resonance, Brief outline of principles of FT-NMR and 13C NMR. Applications of NMR spectroscopy.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Mass Spectroscopy<span class="p">: Principle, Theory, Instrumentation of Mass Spectroscopy, Different types of ionization like electron impact, chemical, field, FAB and MALDI, APCI, ESI, APPI Analyzers of Quadrupole and Time of Flight, Mass fragmentation and its rules, Meta stable ions, Isotopic peaks and Applications of Mass spectroscopy</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Chromatography<span class="p">:  Principle,  apparatus,  instrumentation, chromatographic parameters, factors affecting resolution and applications of the following:</span></p><ol id="l4"><li data-list-text="a)"><p style="padding-left: 38pt;text-indent: -10pt;line-height: 10pt;text-align: left;">Paper chromatography b) Thin Layer chromatography</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">c) Ion exchange chromatography d) Column chromatography</p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: left;">e)  Gas  chromatography  f) High Performance Liquid chromatography</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">g) Affinity chromatography</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="5"><p style="padding-left: 41pt;text-indent: -35pt;line-height: 88%;text-align: justify;">a. <span class="s3">Electrophoresis</span>: Principle, Instrumentation, Working conditions, factors affecting separation and applications of the following:</p><ol id="l5"><li data-list-text="a)"><p style="padding-left: 42pt;text-indent: -14pt;line-height: 9pt;text-align: justify;">Paper electrophoresis b) Gel electrophoresis c) Capillary</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">electrophoresis d) Zone electrophoresis e) Moving boundary electrophoresis f) Iso electric focusing</p><p class="s3" style="padding-left: 41pt;text-indent: -11pt;line-height: 87%;text-align: justify;">b. X ray Crystallography<span class="p">: Production of X rays, Different X ray diffraction methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X- ray diffraction.</span></p></li></ol></li><li data-list-text="6"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: justify;">Immunological assays : <span class="p">RIA (Radio immuno assay), ELISA,</span></p></li></ol><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Bioluminescence assays.</p><p class="s3" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">11</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">5 Hrs</p><ol id="l6"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: left;">Spectrometric Identification of Organic compounds - Robert M Silverstein, Sixth edition, John Wiley &amp; Sons, 2004.</p></li><li data-list-text="2."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: left;">Principles of Instrumental Analysis - Doglas A Skoog, F. James Holler, Timothy A. Nieman, 5th edition, Eastern press, Bangalore, 1998.</p></li><li data-list-text="3."><p style="padding-left: 15pt;text-indent: -10pt;line-height: 11pt;text-align: left;">Instrumental methods of analysis – Willards, 7th edition, CBS publishers.</p></li><li data-list-text="4."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: left;">Practical Pharmaceutical Chemistry – Beckett and Stenlake, Vol II, 4th edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="5."><p style="padding-left: 15pt;text-indent: -10pt;line-height: 11pt;text-align: left;">Organic Spectroscopy - William Kemp, 3rd edition, ELBS, 1991.</p></li><li data-list-text="6."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">Quantitative Analysis of Drugs in Pharmaceutical formulation - P D Sethi, 3rd Edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="7."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 83%;text-align: left;">Pharmaceutical Analysis- Modern methods – Part B - J W Munson, Volume 11, Marcel Dekker Series</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 138pt;text-indent: -39pt;line-height: 113%;text-align: left;">DRUG DELIVERY SYSTEMS (MPH 102T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">SCOPE</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This course is designed to impart knowledge on the area of advances in novel drug delivery systems.</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">OBJECTIVES</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of the course, student shall be able to understand</p><ul id="l7"><li data-list-text="□"><p style="padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: left;">The various approaches for development of novel drug delivery systems.</p></li><li data-list-text="□"><p style="padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: left;">The criteria for selection of drugs and polymers for the development of delivering system</p></li><li data-list-text="□"><p style="padding-left: 41pt;text-indent: -17pt;line-height: 12pt;text-align: left;">The formulation and evaluation of Novel drug delivery systems..</p></li></ul><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 5pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  <span class="s3">Sustained  Release(SR)  and  Controlled  Release  (CR) formulations: </span>Introduction &amp; basic concepts, advantages/ disadvantages, factors influencing, Physicochemical &amp; biological approaches for SR/CR formulation, Mechanism of Drug Delivery from SR/CR formulation. Polymers: introduction, definition, classification, properties and application Dosage Forms for Personalized  Medicine:   Introduction,  Definition, Pharmacogenetics, Categories of Patients for Personalized Medicines: Customized drug delivery systems, Bioelectronic Medicines, 3D printing of pharmaceuticals, Telepharmacy.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l8"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Rate  Controlled  Drug  Delivery  Systems:  <span class="p">Principles  &amp; Fundamentals, Types, Activation; Modulated Drug Delivery Systems;Mechanically activated, pH activated, Enzyme activated, and Osmotic activated Drug Delivery Systems Feedback regulated Drug Delivery Systems; Principles &amp; Fundamentals.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Gastro-Retentive Drug Delivery Systems<span class="p">: Principle, concepts advantages and disadvantages, Modulation of GI transit time approaches to extend GI transit. Buccal Drug Delivery Systems: Principle  of  muco  adhesion,  advantages  and disadvantages, Mechanism of drug permeation, Methods of formulation and its evaluations.</span></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 9pt;text-align: justify;">Occular Drug Delivery Systems<span class="p">: Barriers of drug permeation,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Methods to overcome barriers.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">06</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Transdermal Drug Delivery Systems: <span class="p">Structure of skin and barriers, Penetration enhancers, Transdermal Drug Delivery Systems, Formulation and evaluation.</span></p></li><li data-list-text="6"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: justify;">Protein and Peptide Delivery: <span class="p">Barriers for protein delivery.</span></p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 84%;text-align: justify;">Formulation and Evaluation of delivery systems of proteins and other macromolecules.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="7"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: justify;">Vaccine delivery systems: <span class="p">Vaccines, uptake of antigens, single shot vaccines, mucosal and transdermal delivery of vaccines.</span></p></li></ol><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">08</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">06</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l9"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Y W. Chien, Novel Drug Delivery Systems, 2nd edition, revised and expanded,</p><p style="padding-left: 15pt;text-indent: 0pt;line-height: 11pt;text-align: justify;">Marcel Dekker, Inc., New York, 1992.</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Robinson, J. R., Lee V. H. L, Controlled Drug Delivery Systems, Marcel Dekker,Inc., New York, 1992.</p></li><li data-list-text="3."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Encyclopedia of controlled delivery, Editor- Edith Mathiowitz, Published by WileyInterscience Publication, John Wiley and Sons, Inc, New York! Chichester/Weinheim</p></li><li data-list-text="4."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">N.K. Jain, Controlled and Novel Drug Delivery, CBS Publishers &amp; Distributors, New Delhi, First edition 1997 (reprint in 2001).</p></li><li data-list-text="5."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: justify;">S.P.Vyas and R.K.Khar, Controlled Drug Delivery - concepts and advances, Vallabh Prakashan, New Delhi, First edition 2002</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">JOURNALS</p><ol id="l10"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 15pt;text-indent: -9pt;line-height: 13pt;text-align: left;">Indian Journal of Pharmaceutical Sciences (IPA)</p></li><li data-list-text="2."><p style="padding-left: 15pt;text-indent: -9pt;line-height: 11pt;text-align: left;">Indian drugs (IDMA)</p></li><li data-list-text="3."><p style="padding-left: 15pt;text-indent: -10pt;line-height: 12pt;text-align: left;">Journal of controlled release (Elsevier Sciences) desirable</p></li><li data-list-text="4."><p style="padding-left: 15pt;text-indent: -9pt;line-height: 13pt;text-align: left;">Drug Development and Industrial Pharmacy (Marcel &amp; Decker) desirable</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 138pt;text-indent: -40pt;line-height: 113%;text-align: left;">MODERN PHARMACEUTICS (MPH 103T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">Course designed to impart advanced knowledge and skills required to learn various aspects and concepts at pharmaceutical industries</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of the course, student shall be able to understand</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The elements of preformulation studies.</span></p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">The Active Pharmaceutical Ingredients and Generic drug Product development</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Industrial Management and GMP Considerations.</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Optimization Techniques &amp; Pilot Plant Scale Up Techniques</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Stability Testing, sterilization process &amp; packaging of dosage forms.</span></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">THEORY                                60 HRS</p><ol id="l11"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">a. <span class="s3">Preformation Concepts – </span>Drug Excipient interactions - different methods, kinetics of stability, Stability testing. Theories of dispersion and pharmaceutical Dispersion (Emulsion and Suspension, SMEDDS) preparation and stability Large and small volume parental – physiological and formulation consideration, Manufacturing and evaluation.</p></li></ol><p style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">b. <span class="s3">Optimization  techniques  in  Pharmaceutical  Formulation</span>: Concept and parameters of optimization, Optimization techniques in pharmaceutical formulation and processing. Statistical design, Response surface method, Contour designs, Factorial designs and application in formulation</p><ol id="l12"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Validation : <span class="p">Introduction to Pharmaceutical Validation, Scope &amp; merits of Validation, Validation and calibration of Master plan, ICH &amp; WHO guidelines for calibration and validation of equipments, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ &amp; P.Q. of facilities.</span></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">cGMP &amp; Industrial Management<span class="p">: Objectives and policies of current good manufacturing practices, layout of buildings, services, equipments and their maintenance Production management: Production organization, , materials management, handling and transportation, inventory management and control, production and planning control, Sales forecasting, budget and cost control, industrial and personal relationship. Concept of Total Quality Management.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="4"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Compression and compaction<span class="p">: Physics of tablet compression, compression, consolidation, effect of friction, distribution of forces, compaction profiles. Solubility.</span></p></li><li data-list-text="5"><p class="s3" style="padding-top: 1pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Study of consolidation parameters<span class="p">; Diffusion parameters, Dissolution parameters and Pharmacokinetic parameters, Heckel plots, Similarity factors – f2 and f1, Higuchi and Peppas plot, Linearity Concept of significance, Standard deviation , Chi square test, students T-test , ANOVA test.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">10</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s3" style="padding-top: 8pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l13"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Theory and Practice of Industrial Pharmacy By Lachmann and Libermann</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Pharmaceutical dosage forms: Tablets Vol. 1-3 by Leon Lachmann.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Pharmaceutical Dosage forms: Disperse systems, Vol, 1-2; By Leon Lachmann.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Pharmaceutical Dosage forms: Parenteral medications Vol. 1-2; By Leon Lachmann.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Modern Pharmaceutics; By Gillbert and S. Banker.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Remington’s Pharmaceutical Sciences.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Advances in Pharmaceutical Sciences Vol. 1-5; By H.S. Bean &amp; A.H. Beckett.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Physical Pharmacy; By Alfred martin</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Bentley’s Textbook of Pharmaceutics – by Rawlins.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Good manufacturing practices for Pharmaceuticals: A plan for total quality control, Second edition; By Sidney H. Willig.</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quality Assurance Guide; By Organization of Pharmaceutical producers of India.</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Drug formulation manual; By D.P.S. Kohli and D.H.Shah. Eastern publishers, New Delhi.</p></li><li data-list-text="13."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 10pt;text-align: left;">How to practice GMPs; By P.P.Sharma. Vandhana Publications, Agra.</p></li><li data-list-text="14."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Pharmaceutical Process Validation; By Fra. R. Berry and Robert A. Nash.</p></li><li data-list-text="15."><p style="padding-left: 27pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Pharmaceutical Preformulations; By J.J. Wells.</p></li><li data-list-text="16."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Applied production and operations management; By Evans, Anderson, Sweeney and Williams.</p></li><li data-list-text="17."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Encyclopaedia of Pharmaceutical technology, Vol I – III.</p></li></ol></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 105pt;text-indent: 0pt;line-height: 113%;text-align: center;">REGULATORY AFFAIRS (MPH 104T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Course designed to impart advanced knowledge and skills required to learn the concept of generic drug and their development, various regulatory filings in different countries, different phases of clinical trials and submitting regulatory documents : filing process of IND, NDA and ANDA</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 11pt;text-align: left;">  <span class="p">To know the approval process of</span></p><p class="s3" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">To know the chemistry, manufacturing controls and their regulatory importance</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 10pt;text-align: left;">  <span class="p">To learn the documentation requirements for</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">To learn the importance and</span></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Objectives:</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Upon completion of the course, it is expected that the students will be able to understand</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 87%;text-align: left;">  <span class="p">The Concepts of innovator and generic drugs, drug development process</span></p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: left;">  <span class="p">The Regulatory guidance’s and guidelines for filing and approval process</span></p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">Preparation of Dossiers and their submission to regulatory agencies in different countries</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Post approval regulatory requirements for actives and drug products</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Submission of global documents in CTD/ eCTD formats</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Clinical trials requirements for approvals for conducting clinical trials</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Pharmacovigilence and process of monitoring in clinical trials.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  a.   <span class="s3">Documentation in  Pharmaceutical  industry</span>:  Master formula record, DMF (Drug Master File), distribution records. Generic drugs product development Introduction , Hatch- Waxman act and amendments, CFR (CODE OF FEDERAL REGULATION) ,drug product performance, in-vitro, ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in –vivo, scale up process approval changes, post marketing surveillance, outsourcing BA and BE to CRO.</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 9pt;text-align: left;">b.   <span class="s3">Regulatory requirement for product approval</span>: API,</p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 84%;text-align: left;">biologics, novel, therapies obtaining NDA, ANDA for generic drugs ways and means of US registration for foreign drugs</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><ol id="l14"><li data-list-text="2"><p style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">CMC, post approval regulatory affairs. Regulation for combination products and medical devices.CTD and ECTD format, industry and FDA liaison. ICH - Guidelines of ICH-Q, S E, M. Regulatory requirements of EU, MHRA, TGA and ROW countries.</p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: justify;">Non clinical drug development: <span class="p">Global submission of IND, NDA, ANDA. Investigation of medicinal products dossier, dossier (IMPD) and investigator brochure (IB).</span></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 10pt;text-align: justify;">Clinical trials: <span class="p">Developing clinical trial protocols. Institutional</span></p></li></ol><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">review board/ independent ethics committee Formulation and working procedures informed Consent process and procedures. HIPAA-  new, requirement  to  clinical  study  process, pharmacovigilance safety monitoring in clinical trials.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l15"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 19pt;text-indent: -14pt;line-height: 86%;text-align: left;">Generic Drug Product Development, Solid Oral Dosage forms, Leon Shargel and IsaderKaufer,Marcel Dekker series, Vol.143</p></li><li data-list-text="2."><p style="padding-left: 17pt;text-indent: -11pt;line-height: 11pt;text-align: left;">The Pharmaceutical Regulatory Process, Second Edition Edited by Ira R.</p><p style="padding-left: 19pt;text-indent: 0pt;line-height: 86%;text-align: left;">Berry and Robert P.Martin, Drugs and the Pharmaceutical Sciences,Vol.185, Informa Health care Publishers.</p></li><li data-list-text="3."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 86%;text-align: left;">New Drug Approval Process: Accelerating Global Registrations By Richard A Guarino, MD,5th edition, Drugs and the Pharmaceutical Sciences,Vol.190.</p></li><li data-list-text="4."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 86%;text-align: left;">Guidebook for drug regulatory submissions / Sandy Weinberg. By John Wiley &amp; Sons.Inc.</p></li><li data-list-text="5."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 86%;text-align: left;">FDA regulatory affairs: a guide for prescription drugs, medical devices, and biologics/edited By Douglas J. Pisano, David Mantus.</p></li><li data-list-text="6."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 86%;text-align: left;">Clinical Trials and Human Research: A Practical Guide to Regulatory Compliance By Fay A.Rozovsky and Rodney K. Adams</p></li><li data-list-text="7."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 11pt;text-align: left;"><a href="http://www.ich.org/">www.ich.org/</a></p></li><li data-list-text="8."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;"><a href="http://www.fda.gov/">www.fda.gov/</a></p></li><li data-list-text="9."><p style="padding-left: 5pt;text-indent: 0pt;line-height: 90%;text-align: left;"><a href="http://www.tga.gov.au/tga-basics" class="a" target="_blank">europa.eu/index_en.htm 10.https://</a><a href="http://www.tga.gov.au/tga-basics" target="_blank">www.tga.gov.au/tga-basics</a></p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 141pt;text-indent: -55pt;line-height: 113%;text-align: left;">PHARMACEUTICS PRACTICALS - I (MPH 105P)</p><ol id="l16"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 19pt;text-indent: -14pt;line-height: 85%;text-align: left;">Analysis of pharmacopoeial compounds and their formulations by UV Vis spectrophotometer</p></li><li data-list-text="2."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Simultaneous estimation of multi component containing formulations by UV</p><p style="padding-left: 19pt;text-indent: 0pt;line-height: 12pt;text-align: left;">spectrophotometry</p></li><li data-list-text="3."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Experiments based on HPLC</p></li><li data-list-text="4."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Experiments based on Gas Chromatography</p></li><li data-list-text="5."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Estimation of riboflavin/quinine sulphate by fluorimetry</p></li><li data-list-text="6."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Estimation of sodium/potassium by flame photometry</p></li><li data-list-text="7."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;">To perform <span class="s3">In-vitro </span>dissolution profile of CR/ SR marketed formulation</p></li><li data-list-text="8."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Formulation and evaluation of sustained release matrix tablets</p></li><li data-list-text="9."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Formulation and evaluation osmotically controlled DDS</p></li><li data-list-text="10."><p style="padding-left: 19pt;text-indent: -14pt;line-height: 86%;text-align: left;">Preparation and evaluation of Floating DDS- hydro dynamically balanced DDS</p></li><li data-list-text="11."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Formulation and evaluation of Muco adhesive tablets.</p></li><li data-list-text="12."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Formulation and evaluation of trans dermal patches.</p></li><li data-list-text="13."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 12pt;text-align: left;">To carry out preformulation studies of tablets.</p></li><li data-list-text="14."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 12pt;text-align: left;">To study the effect of compressional force on tablets disintegration time.</p></li><li data-list-text="15."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 12pt;text-align: left;">To study Micromeritic properties of powders and granulation.</p></li><li data-list-text="16."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 12pt;text-align: left;">To study the effect of particle size on dissolution of a tablet.</p></li><li data-list-text="17."><p style="padding-left: 20pt;text-indent: -14pt;line-height: 13pt;text-align: left;">To study the effect of binders on dissolution of a tablet.</p></li><li data-list-text="18."><p style="padding-top: 1pt;padding-left: 19pt;text-indent: -14pt;line-height: 83%;text-align: left;">To plot Heckal plot, Higuchi and peppas plot and determine similarity factors.</p></li></ol></body></html>
